Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism

American Journal of Clinical Nutrition

Volumn 89, Issue 1, 2009, Pages 425-430

  James, S Jill ^a,b   Melnyk, Stepan ^a   Fuchs, George ^a   Reid, Tyra ^a   Jernigan, Stefanie ^a   Pavliv, Oleksandra ^a   Hubanks, Amanda ^a   Gaylor, David W ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; CYSTEINYLGLYCINE; DISULFIDE; FOLINIC ACID; GLUTATHIONE; MECOBALAMIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INFANTILE AUTISM; METABOLIC DISORDER; METHYLATION; OPEN STUDY; OXIDATION; OXIDATION REDUCTION STATE; PRESCHOOL CHILD; SCHOOL CHILD;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETARY SUPPLEMENTS; FEMALE; GLUTATHIONE; HUMANS; LEUCOVORIN; MALE; METHYLATION; NUTRITIONAL STATUS; OXIDATION-REDUCTION; OXIDATIVE STRESS; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 58149379391     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.26615     Document Type: Article

References (40)

1. Miller AL. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 2003;8:7-19.
2. Muntjewerff JW, Van der Put N, Eskes T, et al. Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia. Psychiatry Res 2003;121:1-9.
3. Giordano V, Peluso G, Iannuccelli M, Benatti P, Nicolai R, Calvani M. Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia. Neurochem Res 2007;32:555-67.
4. Serra JA, Dominguez RO, de Lustig ES, et al. Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients. J Neural Transm 2001;108:1135-48.
5. Pennington K, Beasley CL, Dicker P, et al. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry (Epub ahead of print 2007).
6. James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004;80:1611-7.
7. James SJ, Melnyk S, Jernigan S, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006;141:947-56.
8. Droge W, Breitkreutz R. Glutathione and immune function. Proc Nutr Soc 2000;59:595-600.
9. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 2003;333:19-39.
10. Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem Pharmacol 2006;71:551-64.
11. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-212.
12. Reid M, Jahoor F. Glutathione in disease. Curr Opin Clin Nutr Metab Care 2001;4:65-71.
13. Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology 2006;13:171-81.
14. Kern JK, Jones AM. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006;9:485-99.
15. Yorbik O, Sayal A, Akay C, Akbiyik DI, Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 2002;67:341-3.
16. Zoroglu SS, Armutcu F, Ozen S, et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 2004;254:143-7.
17. Zoroglu SS, Yurekli M, Meram I, et al. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 2003;21:55-60.
18. Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005;17:485-95.
19. Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, Wagner GC. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids 2005;73:379-84.
20. Arnold GL, Hyman SL, Mooney RA, Kirby RS. Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord 2003;33:449-54.
21. Molloy CA, Manning-Court P. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism 2003;7:165-71.
22. Horvath K, Perman JA. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 2002;4:251-8.
23. Melnyk S, Pogribna M, Pogribny I, Hine RJ, James SJ. A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection. J Nutr Biochem 1999;10:490-7.
24. Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5′-phosphate concentrations. Clin Chem 2000;46:265-72.
25. Olteanu H, Banerjee R. Redundancy in the pathway for redox regulation of mammalian methionine synthase-reductive activation by the dual flavoprotein, novel reductase 1. J Biol Chem 2003;278:38310-4.
26. Castro C, Millian NS, Garrow TA. Liver betaine-homocysteine S-methyltransferase activity undergoes a redox switch at the active site zinc. Arch Biochem Biophys 2008;472:26-33.
27. Mosharov E, Cranford MR, Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000;39:13005-11.
28. Avila MA, Carretero MV, Rodriguez EN, Mato JM. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology 1998;114:364-71.
29. Prudova A, Bauman Z, Braun A, Vitvitsky V, Lu SC, Banerjee R. S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc Natl Acad Sci USA 2006;103:6489-94.
30. Banerjee R, Zou CG. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein. Arch Biochem Biophys 2005;433:144-56.
31. Zou CG, Banerjee R. Homocysteine and redox signaling. Antioxid Redox Signal 2005;7:547-59.
32. Reed MC, Nijhout HF, Neuhouser ML, et al. A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr 2006;136:2653-61.
33. Liang LP, Patel M. Seizure-induced changes in mitochondrial redox status. Free Radic Biol Med 2006;40:316-22.
34. Meister A. Metabolism and function of glutathione: an overview. Biochem Soc Trans 1982;10:78-9.
35. Griffith OW, Mulcahy RT. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv Enzymol Relat Areas Mol Biol 1999;73:209-67.
36. Jyonouchi H, Sun SN, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 2002;46:76-84.
37. White JF. Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 2003;228:639-49.
38. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005;57:67-81.
39. Hanson E, Kalish LA, Bunce E, et al. Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. J Autism Dev Disord 2007;37:628-36.
40. Hyman SL, Levy SE. Introduction: novel therapies in developmental disabilities: hope, reason, and evidence. Ment Retard Dev Disabil Res Rev 2005;11:107-9.